Literature DB >> 15124197

Summary workshop report: biopharmaceutics classification system--implementation challenges and extension opportunities.

James E Polli1, Lawrence X Yu, Jack A Cook, Gordon L Amidon, Ronald T Borchardt, Beth A Burnside, Philip S Burton, Mei-Ling Chen, Dale P Conner, Patrick J Faustino, Amale A Hawi, Ajaz S Hussain, Hemant N Joshi, Gloria Kwei, Vincent H L Lee, Lawrence J Lesko, Robert A Lipper, Alice E Loper, Shriniwas G Nerurkar, Joseph W Polli, Dilip R Sanvordeker, Rajneesh Taneja, Ramana S Uppoor, Chandra S Vattikonda, Ian Wilding, Guohua Zhang.   

Abstract

Mesh：

Year:  2004        PMID： 15124197     DOI： 10.1002/jps.20064

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  17 in total

1.  Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the Biopharmaceutic Classification System.

Authors:  Elena Ramirez; Olga Laosa; Pedro Guerra; Blanca Duque; Beatriz Mosquera; Alberto M Borobia; Suhua H Lei; Antonio J Carcas; Jesus Frias
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

2.  Effects of commonly used excipients on the expression of CYP3A4 in colon and liver cells.

Authors:  Leslie Tompkins; Caitlin Lynch; Sam Haidar; James Polli; Hongbing Wang
Journal:  Pharm Res       Date:  2010-05-26       Impact factor: 4.200

3.  Exploring different strategies for imbalanced ADME data problem: case study on Caco-2 permeability modeling.

Authors:  Hai Pham-The; Gerardo Casañola-Martin; Teresa Garrigues; Marival Bermejo; Isabel González-Álvarez; Nam Nguyen-Hai; Miguel Ángel Cabrera-Pérez; Huong Le-Thi-Thu
Journal:  Mol Divers       Date:  2015-12-07       Impact factor: 2.943

Review 4.  Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system.

Authors:  Chi-Yuan Wu; Leslie Z Benet
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

5.  The use of BDDCS in classifying the permeability of marketed drugs.

Authors:  Leslie Z Benet; Gordon L Amidon; Dirk M Barends; Hans Lennernäs; James E Polli; Vinod P Shah; Salomon A Stavchansky; Lawrence X Yu
Journal:  Pharm Res       Date:  2008-01-31       Impact factor: 4.200

6.  Pharmaceutical quality by design: product and process development, understanding, and control.

Authors:  Lawrence X Yu
Journal:  Pharm Res       Date:  2008-01-10       Impact factor: 4.200

7.  An investigation into the importance of "very rapid dissolution" criteria for drug bioequivalence demonstration using gastrointestinal simulation technology.

Authors:  Ivan Kovacevi; Jelena Parojci; Marija Tubi-Grozdanis; Peter Langguth
Journal:  AAPS J       Date:  2009-05-20       Impact factor: 4.009

8.  Summary workshop report: bioequivalence, biopharmaceutics classification system, and beyond.

Authors:  James E Polli; Bertil S I Abrahamsson; Lawrence X Yu; Gordon L Amidon; John M Baldoni; Jack A Cook; Paul Fackler; Kerry Hartauer; Gordon Johnston; Steve L Krill; Robert A Lipper; Waseem A Malick; Vinod P Shah; Duxin Sun; Helen N Winkle; Yunhui Wu; Hua Zhang
Journal:  AAPS J       Date:  2008-08-05       Impact factor: 4.009

9.  In vitro-in vivo correlation of efavirenz tablets using GastroPlus®.

Authors:  Thiago da Silva Honório; Eduardo Costa Pinto; Helvécio Vinicius A Rocha; Valeria Sant'Anna Dantas Esteves; Tereza Cristina dos Santos; Helena Carla Rangel Castro; Carlos Rangel Rodrigues; Valeria Pereira de Sousa; Lucio Mendes Cabral
Journal:  AAPS PharmSciTech       Date:  2013-08-14       Impact factor: 3.246

10.  Considerations for a Pediatric Biopharmaceutics Classification System (BCS): application to five drugs.

Authors:  Shivani V Gandhi; William Rodriguez; Mansoor Khan; James E Polli
Journal:  AAPS PharmSciTech       Date:  2014-02-21       Impact factor: 3.246
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.